Rani Therapeutics News: Human safety study of its robo biologic pill completed
Posted by
www.biotecnika.org
Rani Therapeutics in News Rani Therapeutics has completed the initial
human safety study of its pill designed to provide injectable
therapies from inside the digestive tract. Rani Therapeutics has
raised $142 million to bring it with its thought poised to potentially
reshape markets dominated by blockbuster injectable biologics across a
variety of signs, which can […]
The post Rani Therapeutics News: Human safety study of its robo
biologic pill completed appeared first on BioTecNika .
https://www.biotecnika.org/2019/03/rani-therapeutics-human-safety-study/
Biotech News
Subscribe to:
Post Comments (Atom)
Post a Comment